Deputy Prime Minister Tatyana Golikova instructed the Russian regions to report on their readiness for vaccination against coronavirus, presenting the subject's plan. She announced this at a meeting with the regions. The transcript was published on the government website. “You must report readiness with the region's vaccination plan,” she said. Golikova noted that the regions will have to provide information on the organization of transportation and storage of the vaccine within the region, the availability of special equipment that meets the requirements established by the order of the Ministry of Health to ensure the temperature in accordance with the instructions for the use of the Sputnik V vaccine. In addition, the regions need to provide information on the number of medical personnel trained for vaccination and on the list of vaccine storage and vaccination sites, including information on the possibility of bringing citizens to the vaccination sites. On November 26, the press secretary of the Russian President Dmitry Peskov [cursed] (https://rns.online/society/V-Kremle-oboznachili-sroki-i-format-vaktsinatsii-ot-koronavirusa--2020-11-26/), that mass vaccination against coronavirus should begin before the New Year, RIA Novosti reported. On August 11, Russia registered the world's first coronavirus vaccine, dubbed Sputnik V. The drug was developed by the N.N. N.F. Gamalei. The vaccine underwent clinical trials in June and July. The Russian Direct Investment Fund reported that according to the results of the first interim analysis of the third phase of clinical trials, the effectiveness of Sputnik V in Russia was 92%. On October 14, Russian President Vladimir Putin announced the registration of the second coronavirus vaccine developed by the Novosibirsk Center "Vector". She received the name "EpiVacCorona". It can go into civil circulation on December 10, and in 2021 it will appear in all Russian regions, said Alexander Ryzhikov, head of the department of zoonotic infections and influenza at the Vector Center for Virology and Biotechnology.